Liangjian Ma
Overview
Explore the profile of Liangjian Ma including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
2
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ma L, Huang W, Liang X, Li H, Yu W, Liu L, et al.
Cell Death Discov
. 2025 Feb;
11(1):55.
PMID: 39922821
Endometrial cancer (EC) is a significant health threat to women, with recurrence after treatment posing a major challenge. While abnormal cholesterol metabolism has been implicated in EC progression, the underlying...
2.
Li Y, He R, Qin X, Zhu Q, Ma L, Liang X
PeerJ
. 2024 Apr;
12:e17251.
PMID: 38646488
The occupational chemical 4-Vinylcyclohexene diepoxide (VCD) is a reproductively toxic environmental pollutant that causes follicular failure, leading to premature ovarian insufficiency (POI), which significantly impacts a woman's physical health and...
3.
Ma J, Yao Z, Ma L, Zhu Q, Zhang J, Li L, et al.
J Cancer
. 2024 Apr;
15(9):2627-2645.
PMID: 38577616
The incidence and mortality of gynecological tumors are progressively increasing due to factors such as obesity, viral infection, unhealthy habits, as well as social and economic pressures. Consequently, it has...
4.
Ma L, Huang W, Liang X, Bai G, Wang X, Jiang H, et al.
Cancer Sci
. 2023 Jul;
114(9):3595-3607.
PMID: 37438885
Endometrial cancer (EC) is a common malignant tumor that lacks any therapeutic target and, in many cases, recurrence is the leading ca use of morbidity and mortality in women. Widely...
5.
Yu F, Lin L, Sun J, Pan J, Liao Y, Pan Y, et al.
Oxid Med Cell Longev
. 2023 Feb;
2023:5964723.
PMID: 36743691
Congenital disorders of glycosylation (CDG) are severe metabolic disorders caused by an imbalance in the glycosylation pathway. Phosphomannomutase2 (PMM2-CDG), the most prevalent CDG, is mainly due to the disorder of...